About 200 reports

Allergy Immunotherapy market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Allergy Immunotherapy Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Allergy Immunotherapy types, applications. Further, Allergy...

  • Allergy Immunotherapy
  • World

Immunotherapy Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Immunotherapy Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Immunotherapy Drugs types, applications. Further, Immunotherapy...

  • Immunotherapy
  • World

The global allergy immunotherapies market reached a value of US$ 2.56 Billion in 2021. Looking forward, the analyst expects the marketto reach US$ 4.63 Billion by 2027, exhibiting a CAGR of 10.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Allergy Immunotherapy
  • World
  • Allergy Prevalence
  • Health Expenditure

Major players in the drugs for immunotherapy market are F. Hoffmann-La Roche Ltd., Novartis AG, Amgen, Inc., AbbVie, Inc., and Merck & Co. Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc., Johnson & Johnson and UbiVac. The global drugs for immunotherapy market is expected to grow from $186.39 billion...

  • Immunotherapy
  • World
  • United States
  • Middle East
  • APAC
  • United Kingdom
  • Cancer Incidence

Market Introduction Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies.Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy...

  • Allergy Immunotherapy
  • Middle East
  • Africa
  • Allergy Prevalence
  • Drug Approval

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Immunotherapy Drugs Market Report The global immunotherapy drugs market was valued at USD 169.47 billion in 2020 and is expected to reach USD 326.36 billion by 2026, growing at a CAGR of 11.54%. The major factor responsible for growth...

  • Immunotherapy
  • World

This report provides you with a landscape description and analysis of direct in vivo delivery of nucleic acid-encoded antibodies employing DNA and mRNA platform technologies from an industry perspective as of July 2021. In vivo gene-encoded antibody delivery is an elegant approach to address many of the limitations of conventional therapeutic...

  • Therapy
  • Immunotherapy
  • Gene Therapy
  • World
  • United States
  • North America
  • Drug Approval
  • Number Of Employees

The Asia Pacific allergy immunotherapies market was valued at US$ 697.5 million in 2019 and is projected to reach US$ 871.08 million by 2027; it is expected to grow at a CAGR of 11.5 % during the forecast period. The Asia Pacific allergy immunotherapies market is expected to witness substantial growth during the forecast period owing...

  • Allergy Immunotherapy
  • APAC
  • Allergy Prevalence
  • Processed Food Consumption

Major players in the drugs for immunotherapy market are F. Hoffmann-La Roche Ltd, Novartis AG, Amgen, Inc., AbbVie, Inc., and Merck & Co. Inc. The global drugs for immunotherapy market is expected to grow from $149.31 billion in 2020 to $160.43 billion in 2021 at a compound annual growth rate (CAGR) of 7.4%. The growth is mainly due...

  • Immunotherapy
  • World
  • United States
  • APAC
  • United Kingdom
  • Cancer Incidence

The Europe allergy immunotherapies market was valued at US$ 544.14 million in 2019 and is projected to reach US$ 1,228.14 million by 2027; it is expected to grow at a CAGR of 10.8% during 2020–2027. The increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations are the key factors fueling...

  • Allergy Immunotherapy
  • Europe
  • Health Expenditure
  • Allergy Prevalence

The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3 % during the forecast period. This can be attributed to the increasing developments in the healthcare sector. The rising initiatives by various research...

  • Allergy Immunotherapy
  • North America
  • Drug Approval
  • Allergy Prevalence

The Allergy Immunotherapies market was valued at US$ million 1,819.18 in 2019 and is projected to reach US$ 4,185.89 million by 2027; it is expected to grow at a CAGR of 11.1% from 2020 to 2027. The growth of the allergy immunotherapies market is mainly attributed to factors such as growing prevalence of allergic disorders and technological...

  • Allergy Immunotherapy
  • APAC
  • World
  • Allergy Prevalence
  • Drug Approval

Global Allergy Immunotherapies Market 2021-2025 The analyst has been monitoring the allergy immunotherapies market and it is poised to grow by $ 713.56 mn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. Our report on allergy immunotherapies market provides a holistic analysis, market size...

  • Allergy Immunotherapy
  • World
  • Allergy Prevalence

Allergy Immunotherapy Market Report Overview Allergy Immunotherapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Allergy Immunotherapy market types and applications. It is a focused study on Allergy Immunotherapy market space including...

  • Allergy Immunotherapy
  • World
  • Health Provider Density

Immunotherapy Drugs Market Report Overview Immunotherapy Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Immunotherapy Drugs market types and applications. It is a focused study on Immunotherapy Drugs market space including global...

  • Immunotherapy
  • World
  • Health Provider Density

The immunotherapy drugs market is projected to grow at a CAGR of 11.0% during the forecast period (2020–2025). The global immunotherapy drugs market is projected to reach USD 274.6 billion by 2025 from USD 163.0 billion in 2020, at a CAGR of 11.0 % during the forecast period. Market growth is primarily driven by the rising demand for immunotherapies...

  • Immunotherapy
  • APAC
  • Cancer Incidence
  • Drug Approval

Report Scope: The global immunotherapy market can be segmented into the following types: checkpoint inhibitors, monoclonal antibodies, interferons and interleukins. This report does not include other immunotherapies such as vaccines and hormones. The scope of the report includes an overview of the global market and...

  • Immunotherapy
  • Monoclonal Antibody
  • World

Abstract: - Global Allergy Immunotherapy Market to Reach $3.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Allergy Immunotherapy estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at aCAGR of 9.3% over the period 2020-2027. Subcutaneous...

  • Allergy Immunotherapy
  • World
  • China
  • United States

Abstract: - Global Immunotherapy Drugs Market to Reach $361.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Immunotherapy Drugs estimated at US$154.9 Billion in the year 2020, is projected to reach a revised size of US$361.6 Billion by 2027, growing at a CAGR of 12.9% over the analysis period 2020-2027....

  • Infectious Disease
  • Immunotherapy
  • World
  • China
  • United States

INTRODUCTION In recent years, adoptive T-cell therapy (ACT) has emerged as a potent and viable type of therapeutic intervention, which is applicable to a variety of oncological and non-oncological indications. Owing to its obvious benefits, which include high target specificity, customization potential and the ability...

  • Immunotherapy
  • World
  • APAC

Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis, and Celltrion. The global biosimilar lymphocyte modulator market is expected to grow from $1.16 billion in 2021 to $1.34 billion in 2022 at a compound annual growth rate (CAGR) of 15.4%. The growth is mainly due to the companies resuming...

  • Immunotherapy
  • Biosimilar
  • World
  • United States
  • Middle East
  • APAC

Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis, and Celltrion. The global biosimilar lymphocyte modulator market is expected to grow from $1.22 billion in 2020 to $1.31 billion in 2021 at a compound annual growth rate (CAGR) of 7.4%. The growth is mainly due to the companies resuming...

  • Immunotherapy
  • Biosimilar
  • World
  • United States
  • APAC

Oncolytic Virus Immunotherapy Market – Scope of the Report This report on the global oncolytic virus immunotherapy market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030.The report provides revenue of...

  • Immunotherapy
  • World

Abstract: - Global Veterinary Oncology Market to Reach $400.2 Million by 2027 - Amid the COVID-19 crisis, the global market for Veterinary Oncology estimated at US$215.4 Million in the year 2020, is projected to reach a revised size of US$400.2 Million by 2027, growing at a CAGR of 9.3% over the analysis period 2020-2027....

  • Immunotherapy
  • Chemotherapy
  • Diagnostic Imaging
  • World
  • China
  • United States

"Global Tumor Infiltrating Lymphocytes Immunotherapy Market Opportunity & Clinical Trials Insight 2025" Report Highlights: • Tumor Infiltrating Lymphocytes Immunotherapy Pipeline: 3 Therapies • Highest Phase of Development for Tumor Infiltrating Lymphocytes Immunotherapy : Phase II Trials • USA To Dominate...

  • Therapy
  • Immunotherapy
  • Oncology
  • World

Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis and Celltrion. The global lymphocyte modulator market is expected to decline from $1.29 billion in 2019 to $1.21 billion in 2020 at a compound annual growth rate (CAGR) of -5.57%. The decline is mainly due to the COVID-19 outbreak that...

  • Immunotherapy
  • United States
  • World

INTRODUCTION According to the World Health Organization (WHO), cancer is considered to be among the second leading causes of mortality worldwide, accounting for an estimated 10 million deaths annually. In fact, the global cancer burden is anticipated to increase by 70% in the next 20 years, exerting tremendous physical,...

  • Immunotherapy
  • Therapy
  • World
  • APAC
  • Cause-Specific Mortality Rate

The major factors for the growth of the allergy treatment market include the increasing burden of various types of allergies, increased investment by the manufacturers on the development of novel allergic treatments and rising importance for self-medication. The rising cases of allergies are expected to increase the demand of allergy...

  • Allergy Drug
  • Food Allergy
  • Therapy
  • Allergy Immunotherapy
  • Europe
  • APAC
  • Africa
  • South Africa
  • Allergy Prevalence
  • Asthma Prevalence

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal  Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric  Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors,  Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT)  & IDO Inhibitors  Within...

  • Cancer Immunotherapy
  • Immunotherapy
  • Therapy
  • World

"Artificial Immune Modulation Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlights: • Immunotherapy Inspired Design for Artificial Immune Modulation (AIM) • Artificial Immune Modulations for Various Indications • Clinical Trial Insight for AIM: 3 Drugs  • Expected Price Range...

  • Therapy
  • Immunotherapy
  • World